The page is the record's research on the issuer — no analyst, no rating, no view. # Lycia Therapeutics, Inc. (NASDAQ: LYCA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Lycia Therapeutics, Inc., listed on NASDAQ under ticker LYCA. Its ISIN is not on the record and its LEI is not on the record. Its security type is recorded as non-operating entity type (other). Its segment is not on the record. Its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is the United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 37 filings in the twelve months to 2026-11-08, across 12 filing days. The filings comprise 24 directors' dealings, 8 regulatory filings, 4 prospectuses and 1 ad hoc notice. The median gap between filing days is 3 days. The latest filing is dated 2026-11-04, is of type directors' dealings, and sits 4 days before the record date. On NASDAQ, the median cadence gap is 6.0 days, the median filings count is 52 and the median latency is 5.0 days. In the sector, the median cadence gap is 5.5 days, the median filings count is 65.5 and the median latency is 4.0 days. ## Auditor The auditor is not on the record, and its location is not on the record, because the latest annual report cover carries no auditor name tag. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2026-10-20 and 2026-10-22. It holds no delisting and no name change. A domicile change is not on the record, and a segment move is not on the record. The issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2024 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. The market's vintage is sealed. ## Sources 6 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0001806540.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/LYCA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/LYCA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/LYCA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp